Loading...
Atherogenic Dyslipidemia and Combination Pharmacotherapy in Diabetes: Recent Clinical Trials
Patients with type 2 diabetes (T2D) are at a markedly increased risk of cardiovascular disease (CVD). Dyslipidemia is a common risk factor and a strong predictor of CVD in T2D patients. Although statins decrease the incidence of CVD in T2D, residual cardiovascular risk remains high despite the achie...
Na minha lista:
| Main Authors: | , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
SBDR - Society for Biomedical Diabetes Research
2013
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4063096/ https://ncbi.nlm.nih.gov/pubmed/24380092 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1900/RDS.2013.10.191 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|